Showing 3531-3540 of 4062 results for "".
- Ocuphire to Present at Multiple Ophthalmic Conferences in Julyhttps://modernod.com/news/ocuphire-to-present-at-multiple-ophthalmic-conferences-in-july/2479363/Ocuphire Pharma announced that Jay S. Pepose, MD, Medical Advisor and Board Director, will be presenting two papers on presbyopia and reversal of mydriasis (RM) at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting on July 23-27, 2021 and that Mina Sooch, CEO and
- Belkin Laser Announces Corporate Name Change to Belkin Visionhttps://modernod.com/news/belkin-laser-announces-corporate-name-change-to-belkin-vision/2479352/Israel-based medical device company Belkin Laser announced that it will begin operating under the new name of Belkin Vision. The name change is a strategic decision that will better reflect the company’s capability to solve future ophthalmic challenges, according to a company stateme
- Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officerhttps://modernod.com/news/outlook-therapeutics-appoints-c-russell-trenary-iii-as-president-and-chief-executive-officer/2479350/Outlook Therapeutics announced the appointment of C. Russell Trenary III as President, Chief Executive Officer and a member of the Board of Directors. Lawrence A. Kenyon, who has served as Outlook Therapeutics’ President, CEO and CFO since June 2018, will continue serving as CFO and as a member o
- Roche’s Actemra Gains FDA Emergency-Use in Hospitalized COVID-19 Patientshttps://modernod.com/news/roches-actemra-gains-fda-emergency-use-in-hospitalized-covid-19-patients/2479324/The FDA announced that it issued an emergency-use authorization (EUA) to Roche’s Actemra (tocilizumab) for the treatment of COVID-19 in hospitalized adults and paediatric patients, according to FirstWord. Specifically, the IL-6 receptor antagonist is cleared for use in people who are receiv
- Bausch + Lomb Expands Parameters for Bausch + Lomb Ultra Multifocal for Astigmatism Contact Lenseshttps://modernod.com/news/bausch-lomb-expands-parameters-for-bausch-lomb-ultra-multifocal-for-astigmatism-contact-lenses/2479319/Bausch + Lomb announced the US launch of expanded parameters for Bausch + Lomb ULTRA Multifocal for Astigmatism contact lenses. The expansion, which includes the addition of -2.25D and -2.75D cylinder power parameters, will be part of the company’s standard offering of the lens and will ext
- Belkin Laser Appoints Andrew Webb as Chief Commercial Officerhttps://modernod.com/news/belkin-laser-appoints-andrew-webb-as-chief-commercial-officer/2479316/Israel-based medical device company Belkin Laser has announced the appointment of Andrew Webb as Chief Commercial Officer. Under Mr. Webb’s guidance, the company’s commercial and go-to-market strategy will be rolled out in anticipation of a controlled launch in
- Tarsus Announces Positive Results of Saturn-1 Trial Evaluating TP-03 for the Treatment of Demodex Blepharitishttps://modernod.com/news/tarsus-pharmaceuticals-announces-positive-results-of-saturn-1-trial-evaluating-tp-03-for-the-treatment-of-demodex-blepharitis/2479309/Tarsus Pharmaceuticals announced that all pre-specified primary and secondary endpoints were met for its pivotal Phase 2b/3 Saturn-1 trial evaluating the company’s novel investigational therapeutic, TP-03 (lotilaner ophthalmic solution, 0.25%), in patients with Demodex blepharitis. Results demons
- Santen to Host Dry Eye Disease Panel at Inaugural European Dry Eye Society Congress (EuDEC)https://modernod.com/news/santen-to-host-dry-eye-disease-panel-at-inaugural-european-dry-eye-society-congress-eudec/2479305/Santen EMEA announced it is taking place in the inaugural European Dry Eye Society Congress (EuDEC), which will be held virtually on June 18-19, 2021. Santen will host an international panel of experts for an online s
- CORE Summarizes BCLA CLEAR Guidance for Contact Lens Practitionershttps://modernod.com/news/core-summarizes-bcla-clear-guidance-for-contact-lens-practitioners/2479297/The latest issue of
- Schwind Receives “SME Innovation Award“ in Germanyhttps://modernod.com/news/schwind-receives-sme-innovation-award-in-germany/2479288/Schwind eye-tech-solutions is one of the most innovative small and medium sized enterprises (SMEs) 2021/2022, according to a survey conducted by the independent Deutsche Gesellschaft für Verbraucherstudien (DtGV) in